About
Robert Mittendorff, MD is a General Partner and Global Head of Healthcare at B Capital, focusing on venture and growth investments in healthcare companies. He previously spent nearly a decade at Norwest Venture Partners as Partner and Co-Head of Healthcare, and earlier held an executive role at Hansen Medical, worked in portfolio strategy at Merck, and consulted at BCG. He is a board-certified emergency physician with an MD from Harvard Medical School, an MBA from Harvard Business School, and a BS in biomedical engineering from Johns Hopkins University.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- B CapitalGeneral Partner and Global Head of Healthcarecurrent2021 — presentSan Francisco, California, United States
- ARTBIOMember Board of Directorscurrent2025 — present
- EvommuneBoard Observercurrent2024 — present
- Nuvig Therapeutics Inc.Board Observercurrent2024 — present
- Capital RxMember Board of Directorscurrent2022 — presentNew York, United States
- CARRICK THERAPEUTICS UK LIMITEDMember Board of Directorscurrent2023 — presentDublin, County Dublin, Ireland
- CarlsmedMember Board Of Directorscurrent2022 — presentCarlsbad, California, United States
- Lively, Inc.Member Board Of Directorscurrent2021 — presentSan Francisco Bay Area
- HotSpot Therapeutics, Inc.Member Board of Directorscurrent2021 — presentBoston, MA
- Volastra TherapeuticsMember Board of Directorscurrent2024 — presentNew York City Metropolitan Area
- Triumvira Immunologics, Inc.Member Board of Directorscurrent2022 — presentOntario, Canada
- AtomwiseMember Board of Directorscurrent2023 — present
- PicnicHealthInvestorcurrent2022 — present
- Nalu Medical, Inc.Member Board of Directors2024 — 2026San Diego, California, United States
- AetionBoard Observer2021 — 2025New York, United States
- Kaiser PermanenteEmergency Physician2008 — 2021
- Norwest Venture PartnersCo-Head Healthcare Group2020 — 2021San Francisco Bay Area
- Norwest Venture PartnersPartner2012 — 2021Palo Alto, CA
- Route 92 MedicalBoard Observer2019 — 2021San Mateo, California, United States
- Neocis Inc.Member Board Of Directors2019 — 2021Miami, Florida
Education
- Harvard Business SchoolMBA
- Harvard Medical SchoolMD
- The Johns Hopkins UniversityB.S. (high honors), Biomedical/Electrical Engineering1994 — 1998
- Stanford University School of MedicineDepartment of Surgery, Emergency Medicine Residency Program Graduate
- King's College LondonMaster of Arts - MA, International Affairs
- Massachusetts Institute of TechnologyGraduate Program of Study (ABT due to medical residency), Systems Engineering/Financial Engineering2002 — 2005
Skills & more
+12 more
Disaster MedicineMachine LearningArtificial Intelligence (AI)Artificial Neural NetworksDeep LearningData SciencePython (Programming Language)Venture CapitalStart-upsSaaSStrategyStrategic PlanningLanguages Italian · Spanish
- Caltech Data Science and Generative AI Program — Caltech
- MIT Data Science and Machine Learning Certificate — Massachusetts Institute of Technology
- Artificial Intelligence in Pharma and Biotech — MIT Sloan School of Management
- Emergency Medicine Certification — American Board of Emergency Medicine
- Pediatric Advanced Life Support (PALS) — American Heart Association
- Advanced Trauma Life Support (ATLS) — American College of Surgeons
- Advanced Cardiac Life Support (ACLS) — American Heart Association
- FAAEM (Fellow) — American Academy of Emergency Medicine (AAEM)
- Member — American Association for Physician Leadership® (AAPL)
- Stanford Directors College — Stanford Law School
From Robert's professional profile.
Same school
Also attended Harvard Medical School113
+ 107 more
Also attended The Johns Hopkins University196
+ 190 more
Also attended Stanford University School of Medicine67
+ 61 more
Also attended Massachusetts Institute of Technology849
+ 843 more
Shared employers
Also worked at Capital Rx3
Also worked at Lively, Inc.3
Also worked at Triumvira Immunologics, Inc.2
Also worked at Silk Road Medical, Inc.2
Deals · 8
Solve Therapeutics, Inc.Board seat
via B4 Capital · filed Nov 2025 · $120.5M raise
Capital Rx, Inc.Board seat
via B4 Capital · filed Sep 2025 · $232.9M raise
Volastra Therapeutics, Inc.Board seat
via B4 Capital · filed Sep 2025 · $30.1M raise
CARLSMED, INC.Board seat
via B4 Capital · filed Feb 2025 · $64.5M raise
AktanaBoard seat
via B4 Capital · filed Oct 2020 · $30M raise
NeocisBoard seat
via B Capital Group · filed Jul 2019 · $30M raise
Impel NeuropharmaBoard seat
via B Capital Group · filed Jul 2019 · $1.6M raise
Silk Road MedicalBoard seat
via B Capital Group · filed Jul 2017 · $42M raise
Attribution from SEC filings, press coverage, and firm rosters.

.png)
































